Universe Pharmaceuticals Inc (UPC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Universe Pharmaceuticals Inc (UPC) has a cash flow conversion efficiency ratio of -0.136x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-7.61 Million) by net assets ($56.13 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Universe Pharmaceuticals Inc market cap and net worth for the company's overall valuation and market capitalisation.
Universe Pharmaceuticals Inc - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Universe Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Universe Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Universe Pharmaceuticals Inc ranked by their cash flow conversion efficiency. Explore UPC cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
RBR Group Ltd
AU:RBR
|
-0.301x |
|
Yangaroo Inc
V:YOO
|
0.540x |
|
Atomic Minerals Corp
V:ATOM
|
-0.496x |
|
Tivic Health Systems Inc
NASDAQ:TIVC
|
-0.453x |
|
BioXcel Therapeutics Inc
NASDAQ:BTAI
|
0.112x |
|
Anatara Lifesciences Ltd
AU:ANR
|
-2.561x |
|
Mantex AB
ST:MANTEX
|
-1.685x |
|
Lazydays Holdings Inc
NASDAQ:GORV
|
0.889x |
Annual Cash Flow Conversion Efficiency for Universe Pharmaceuticals Inc (2018–2025)
The table below shows the annual cash flow conversion efficiency of Universe Pharmaceuticals Inc from 2018 to 2025. View Universe Pharmaceuticals Inc stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $56.13 Million | $-5.05 Million | -0.090x | +56.92% |
| 2024-09-30 | $45.50 Million | $-9.51 Million | -0.209x | -837.39% |
| 2023-09-30 | $39.53 Million | $1.12 Million | 0.028x | +200.27% |
| 2022-09-30 | $46.44 Million | $-1.31 Million | -0.028x | +18.99% |
| 2021-09-30 | $58.93 Million | $-2.06 Million | -0.035x | -111.87% |
| 2020-09-30 | $20.80 Million | $6.12 Million | 0.294x | -72.43% |
| 2019-09-30 | $12.38 Million | $13.20 Million | 1.066x | +131.67% |
| 2018-09-30 | $9.68 Million | $4.46 Million | 0.460x | -- |
About Universe Pharmaceuticals Inc
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong … Read more